|
|
|
|
LEADER |
02598aam a2200421uu 4500 |
001 |
000000059782 |
003 |
OSt |
005 |
20240205103758.0 |
008 |
150513b ho ||||| |||| 00| 0 spa d |
040 |
|
|
|a Sistema de Bibliotecas UNAH
|
044 |
|
|
|a HN
|
082 |
0 |
|
|a 327.101- V182
|
100 |
1 |
|
|a Vallejo, Antonio R.
|q Antonio R. Vallejo Armijo
|d 1844-1914
|9 49019
|
245 |
1 |
0 |
|a Réplica [ al Dr. Santiago I. Barberena]
|c Antonio R. Vallejo
|
260 |
|
|
|a Tegucigalpa, Honduras.
|b Imprenta Cultura
|c [19-?]
|
300 |
|
|
|a 20 p.
|b il.
|c 22 cm.
|
500 |
|
|
|a Nota se que Honduras jamás ha recibido reclamaciones por que sus hijos hayan invadido territorio de las vecinas Repúblicas y que se han limitado a sostener sus derechos fundados en justos y legítimos títulos.
|
501 |
|
|
|a La República de el Salvador no tiene ni nunca ha tenido documentos justificativos de poseer territorio hondureño.
|
650 |
|
4 |
|a RECLAMACIONES TERRITORIALES
|9 29882
|
650 |
|
4 |
|a FRONTERAS
|
650 |
|
4 |
|a HONDURAS
|
650 |
|
4 |
|a EL SALVADOR
|9 22222
|
901 |
|
|
|a BINAHON
|
903 |
|
|
|a 19980511 MP MS VG
|
942 |
|
|
|2 ddc
|c FDA
|
999 |
|
|
|c 59782
|d 59782
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170877
|a BLA
|b BLA
|l 0
|o 327.101-V182
|p BLA1307149929
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170878
|a BLA
|b BLA
|l 0
|o 327.101-V182
|p BLA1307149930
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170879
|a BLA
|b BLA
|l 0
|o 327.101-V182
|p BLA1307149931
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170880
|a BVS
|b BVS
|l 0
|o 327.101-V182
|p BVS1307149932
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170881
|a BVS
|b BVS
|l 0
|o 327.101-V182
|p BVS1307149933
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170882
|a BVS
|b BVS
|l 0
|o 327.101-V182
|p BVS1307149934
|y LB
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170883
|a CLRA
|b BH
|d 2022-09-12
|o 327.101-V182
|p 434766
|y FDA
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170884
|a CLRA
|b BH
|d 2022-09-12
|o 327.101-V182
|p 434767
|y FDA
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 170885
|a CLRA
|b BH
|d 2022-04-20
|o 327.101-V182
|p 434917
|y FDA
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101V182
|7 0
|9 381724
|a CLRA
|b BH
|d 2023-02-07
|o 327.101-V182
|p 629136
|r 2023-02-07
|w 2023-02-07
|y FDA
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101_V182
|7 2
|9 383161
|a CLRA
|b BH
|d 2023-07-13
|l 0
|o 327.101- V182
|p 630589
|r 2023-07-13
|w 2023-07-13
|y FDA
|
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 327_000000000000000_101_V182
|7 2
|9 383162
|a CLRA
|b BH
|d 2023-07-13
|l 0
|o 327.101- V182
|p 630590
|r 2023-07-13
|w 2023-07-13
|y FDA
|